▶ 調査レポート

抗炎症性生物製剤の世界市場 2020年

• 英文タイトル:Global Anti-inflammatory Biologics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。抗炎症性生物製剤の世界市場 2020年 / Global Anti-inflammatory Biologics Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / GIR201100716資料のイメージです。• レポートコード:GIR201100716
• 出版社/出版日:GlobalInfoResearch / 2020年10月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、抗炎症性生物製剤の世界市場を調査対象にし、抗炎症性生物製剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(合成型、生物型)、用途別分析(関節炎、呼吸器疾患、皮膚科、消化器科、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:AbbVie、Sun Pharmaceutical Industries Ltd、AstraZeneca PLC、Johnson & Johnson、Roche、Amgen Inc、GlaxoSmithKline、Novartis、Pfizer, Inc、Sanofi
・メーカー別販売量、売上、市場シェア
・抗炎症性生物製剤の地域別市場分析
・抗炎症性生物製剤の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・抗炎症性生物製剤のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・抗炎症性生物製剤のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・抗炎症性生物製剤の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・抗炎症性生物製剤の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・抗炎症性生物製剤の種類別市場規模2015-2020:合成型、生物型
・抗炎症性生物製剤の用途別市場規模2015-2020:関節炎、呼吸器疾患、皮膚科、消化器科、その他
・抗炎症性生物製剤の世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論

Market Overview
The global Anti-inflammatory Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Anti-inflammatory Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Anti-inflammatory Biologics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Anti-inflammatory Biologics market has been segmented into
Synthetic Type
Biological Type

By Application, Anti-inflammatory Biologics has been segmented into:
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-inflammatory Biologics market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-inflammatory Biologics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-inflammatory Biologics market.

The report offers in-depth assessment of the growth and other aspects of the Anti-inflammatory Biologics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Anti-inflammatory Biologics Market Share Analysis
Anti-inflammatory Biologics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-inflammatory Biologics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-inflammatory Biologics sales, revenue and market share for each player covered in this report.

The major players covered in Anti-inflammatory Biologics are:
AbbVie
Sun Pharmaceutical Industries Ltd
AstraZeneca PLC
Johnson & Johnson
Roche
Amgen Inc
GlaxoSmithKline
Novartis
Pfizer, Inc
Sanofi

Among other players domestic and global, Anti-inflammatory Biologics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-inflammatory Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-inflammatory Biologics, with price, sales, revenue and global market share of Anti-inflammatory Biologics in 2018 and 2019.
Chapter 3, the Anti-inflammatory Biologics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-inflammatory Biologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-inflammatory Biologics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-inflammatory Biologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Anti-inflammatory Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-inflammatory Biologics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Synthetic Type
1.2.3 Biological Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-inflammatory Biologics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Overview of Global Anti-inflammatory Biologics Market
1.4.1 Global Anti-inflammatory Biologics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sun Pharmaceutical Industries Ltd
2.2.1 Sun Pharmaceutical Industries Ltd Details
2.2.2 Sun Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sun Pharmaceutical Industries Ltd SWOT Analysis
2.2.4 Sun Pharmaceutical Industries Ltd Product and Services
2.2.5 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca PLC
2.3.1 AstraZeneca PLC Details
2.3.2 AstraZeneca PLC Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca PLC SWOT Analysis
2.3.4 AstraZeneca PLC Product and Services
2.3.5 AstraZeneca PLC Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen Inc
2.6.1 Amgen Inc Details
2.6.2 Amgen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen Inc SWOT Analysis
2.6.4 Amgen Inc Product and Services
2.6.5 Amgen Inc Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline SWOT Analysis
2.7.4 GlaxoSmithKline Product and Services
2.7.5 GlaxoSmithKline Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer, Inc
2.9.1 Pfizer, Inc Details
2.9.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer, Inc SWOT Analysis
2.9.4 Pfizer, Inc Product and Services
2.9.5 Pfizer, Inc Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanofi SWOT Analysis
2.10.4 Sanofi Product and Services
2.10.5 Sanofi Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-inflammatory Biologics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-inflammatory Biologics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-inflammatory Biologics Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-inflammatory Biologics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-inflammatory Biologics Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-inflammatory Biologics Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-inflammatory Biologics Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
4.3 Europe Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
4.5 South America Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-inflammatory Biologics Sales, Revenue and Market Share by Country
5.1.1 North America Anti-inflammatory Biologics Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-inflammatory Biologics Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
5.3 Canada Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-inflammatory Biologics Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-inflammatory Biologics Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-inflammatory Biologics Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
6.3 UK Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
6.4 France Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
6.5 Russia Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
6.6 Italy Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-inflammatory Biologics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-inflammatory Biologics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-inflammatory Biologics Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
7.3 Japan Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
7.4 Korea Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
7.5 India Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
7.7 Australia Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-inflammatory Biologics Sales, Revenue and Market Share by Country
8.1.1 South America Anti-inflammatory Biologics Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-inflammatory Biologics Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-inflammatory Biologics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-inflammatory Biologics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-inflammatory Biologics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-inflammatory Biologics Sales and Market Share by Type (2015-2020)
10.2 Global Anti-inflammatory Biologics Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-inflammatory Biologics Price by Type (2015-2020)
11 Global Anti-inflammatory Biologics Market Segment by Application
11.1 Global Anti-inflammatory Biologics Sales Market Share by Application (2015-2020)
11.2 Global Anti-inflammatory Biologics Revenue Market Share by Application (2015-2020)
11.3 Global Anti-inflammatory Biologics Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-inflammatory Biologics Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-inflammatory Biologics Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-inflammatory Biologics Market Forecast (2021-2025)
12.2.2 Europe Anti-inflammatory Biologics Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-inflammatory Biologics Market Forecast (2021-2025)
12.2.4 South America Anti-inflammatory Biologics Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-inflammatory Biologics Market Forecast (2021-2025)
12.3 Anti-inflammatory Biologics Market Forecast by Type (2021-2025)
12.3.1 Global Anti-inflammatory Biologics Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-inflammatory Biologics Market Share Forecast by Type (2021-2025)
12.4 Anti-inflammatory Biologics Market Forecast by Application (2021-2025)
12.4.1 Global Anti-inflammatory Biologics Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-inflammatory Biologics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Anti-inflammatory Biologics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-inflammatory Biologics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Anti-inflammatory Biologics Major Business
Table 9. AbbVie Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Anti-inflammatory Biologics Product and Services
Table 12. AbbVie Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Major Business
Table 15. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 16. Sun Pharmaceutical Industries Ltd SWOT Analysis
Table 17. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product and Services
Table 18. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca PLC Anti-inflammatory Biologics Major Business
Table 21. AstraZeneca PLC Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 22. AstraZeneca PLC SWOT Analysis
Table 23. AstraZeneca PLC Anti-inflammatory Biologics Product and Services
Table 24. AstraZeneca PLC Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Anti-inflammatory Biologics Major Business
Table 27. Johnson & Johnson Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Anti-inflammatory Biologics Product and Services
Table 30. Johnson & Johnson Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Anti-inflammatory Biologics Major Business
Table 33. Roche Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 34. Roche SWOT Analysis
Table 35. Roche Anti-inflammatory Biologics Product and Services
Table 36. Roche Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 38. Amgen Inc Anti-inflammatory Biologics Major Business
Table 39. Amgen Inc Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 40. Amgen Inc SWOT Analysis
Table 41. Amgen Inc Anti-inflammatory Biologics Product and Services
Table 42. Amgen Inc Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Anti-inflammatory Biologics Major Business
Table 45. GlaxoSmithKline Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 46. GlaxoSmithKline SWOT Analysis
Table 47. GlaxoSmithKline Anti-inflammatory Biologics Product and Services
Table 48. GlaxoSmithKline Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Anti-inflammatory Biologics Major Business
Table 51. Novartis Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Anti-inflammatory Biologics Product and Services
Table 54. Novartis Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer, Inc Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer, Inc Anti-inflammatory Biologics Major Business
Table 57. Pfizer, Inc Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer, Inc SWOT Analysis
Table 59. Pfizer, Inc Anti-inflammatory Biologics Product and Services
Table 60. Pfizer, Inc Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Anti-inflammatory Biologics Major Business
Table 63. Sanofi Anti-inflammatory Biologics Total Revenue (USD Million) (2017-2018)
Table 64. Sanofi SWOT Analysis
Table 65. Sanofi Anti-inflammatory Biologics Product and Services
Table 66. Sanofi Anti-inflammatory Biologics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Anti-inflammatory Biologics Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Anti-inflammatory Biologics Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Anti-inflammatory Biologics Sales by Regions (2015-2020) (K MT)
Table 70. Global Anti-inflammatory Biologics Sales Market Share by Regions (2015-2020)
Table 71. Global Anti-inflammatory Biologics Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 73. North America Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 74. North America Anti-inflammatory Biologics Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Table 76. Europe Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 77. Europe Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 78. Europe Anti-inflammatory Biologics Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Anti-inflammatory Biologics Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Anti-inflammatory Biologics Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Anti-inflammatory Biologics Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 83. South America Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 84. South America Anti-inflammatory Biologics Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Anti-inflammatory Biologics Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Anti-inflammatory Biologics Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Table 90. Global Anti-inflammatory Biologics Sales by Type (2015-2020) (K MT)
Table 91. Global Anti-inflammatory Biologics Sales Share by Type (2015-2020)
Table 92. Global Anti-inflammatory Biologics Revenue by Type (2015-2020) (USD Million)
Table 93. Global Anti-inflammatory Biologics Revenue Share by Type (2015-2020)
Table 94. Global Anti-inflammatory Biologics Sales by Application (2015-2020) (K MT)
Table 95. Global Anti-inflammatory Biologics Sales Share by Application (2015-2020)
Table 96. Global Anti-inflammatory Biologics Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Anti-inflammatory Biologics Market Share Forecast by Regions (2021-2025)
Table 98. Global Anti-inflammatory Biologics Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Anti-inflammatory Biologics Market Share Forecast by Type (2021-2025)
Table 100. Global Anti-inflammatory Biologics Sales Forecast by Application (2021-2025)
Table 101. Global Anti-inflammatory Biologics Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-inflammatory Biologics Picture
Figure 2. Global Sales Market Share of Anti-inflammatory Biologics by Type in 2019
Figure 3. Synthetic Type Picture
Figure 4. Biological Type Picture
Figure 5. Anti-inflammatory Biologics Sales Market Share by Application in 2018
Figure 6. Arthritis Picture
Figure 7. Respiratory Diseases Picture
Figure 8. Dermatology Picture
Figure 9. Gastroenterology Picture
Figure 10. Others Picture
Figure 11. Global Anti-inflammatory Biologics Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Anti-inflammatory Biologics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Anti-inflammatory Biologics Sales Market Share by Manufacturer in 2019
Figure 32. Global Anti-inflammatory Biologics Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Anti-inflammatory Biologics Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Anti-inflammatory Biologics Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Anti-inflammatory Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Anti-inflammatory Biologics Revenue Market Share by Regions (2015-2020)
Figure 39. Global Anti-inflammatory Biologics Revenue Market Share by Regions in 2018
Figure 40. North America Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
Figure 41. Europe Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
Figure 43. South America Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Anti-inflammatory Biologics Sales and Growth Rate (2015-2020)
Figure 45. North America Anti-inflammatory Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Anti-inflammatory Biologics Sales Market Share by Countries (2015-2020)
Figure 47. North America Anti-inflammatory Biologics Sales Market Share by Countries in 2018
Figure 48. North America Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Anti-inflammatory Biologics Revenue Market Share by Countries in 2018
Figure 50. United States Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Anti-inflammatory Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Anti-inflammatory Biologics Revenue Market Share by Countries in 2019
Figure 56. Germany Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Anti-inflammatory Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Anti-inflammatory Biologics Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Anti-inflammatory Biologics Revenue Market Share by Regions 2019
Figure 64. China Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Anti-inflammatory Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Anti-inflammatory Biologics Sales Market Share by Countries in 2019
Figure 71. South America Anti-inflammatory Biologics Revenue Market Share by Countries in 2019
Figure 72. Brazil Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Anti-inflammatory Biologics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Anti-inflammatory Biologics Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Anti-inflammatory Biologics Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Anti-inflammatory Biologics Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Anti-inflammatory Biologics Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Anti-inflammatory Biologics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Anti-inflammatory Biologics Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Anti-inflammatory Biologics Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Anti-inflammatory Biologics Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Anti-inflammatory Biologics Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Anti-inflammatory Biologics Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel